Pasar al contenido principal

NUEVAS ESTRATEGIAS DE CONTROL GLUCEMICO POSTPRANDIAL MEDIANTE TERAPIA CON BOMBA DE INSULINA EN DIABETES TIPO 1

DPI2010-20764-C02-01

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2010
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Guaranteed computation methods for compartmental in-series models under uncertainty

  • de Pereda Sebastián, Diego
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Bondía Company, Jorge|||0000-0001-7286-3719
The pattern of some real phenomenon can be described by compartmental in-series models. Nevertheless, most of these processes are characterized by their variability, which produces that the exact values of the model parameters are uncertain, although they can be bounded by intervals. The aim of this paper is to compute tight solution envelopes that guarantee the inclusion of all possible behaviors of such processes. Current methods, such as monotonicity analysis, enable us to obtain guaranteed solution envelopes. However, if the model includes nonmonotone compartments or parameters, the computation of solution envelopes may produce a significant overestimation. Our proposal consists of performing a change of variables in which the output is unaltered, and the model obtained is monotone with respect to the uncertain parameters. The monotonicity of the new system allows us to compute the output bounds for the original system without overestimation. These model transformations have been developed for linear and non-linear systems. Furthermore, if the conditions are not completely satisfied, a novel method to compute tight solution envelopes is proposed. The methods exposed in this paper have been applied to compute tight solution envelopes for two different models: a linear system for glucose modeling and a non-linear system for an epidemiological model., This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion through Grant DPI-2010-20764-C02-01, and by the Generalitat Valenciana through Grant GV/2012/085.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Experimental blood glucose interval identification of patients with type 1 diabetes

  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Many problems are confronted when characterizing a type 1 diabetic patient such as model mismatches, noisy inputs, measurement errors and huge variability in the glucose profiles. In this work we introduce a new identification method based on interval analysis where variability and model imprecisions are represented by an interval model as parametric uncertainty. The minimization of a composite cost index comprising: (1) the glucose envelope width predicted by the interval model, and (2) a Hausdorff-distance-based prediction error with respect to the envelope, is proposed. The method is evaluated with clinical data consisting in insulin and blood glucose reference measurements from 12 patients for four different lunchtime postprandial periods each. Following a “leave-one-day-out” cross-validation study, model prediction capabilities for validation days were encouraging (medians of: relative error = 5.45%, samples predicted = 57%, prediction width = 79.1 mg/dL). The consideration of the days with maximum patient variability represented as identification days, resulted in improved prediction capabilities for the identified model (medians of: relative error = 0.03%, samples predicted = 96.8%, prediction width = 101.3 mg/dL). Feasibility of interval models identification in the context of type 1 diabetes was demonstrated., The research leading to these results has received funding from the Spanish Ministry of Science and Innovation under grant DPI2010-20764-C02-01, the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement FP7-PEOPLE-2009-IEF, Ref 252085 and the GeneralitatValenciana through Grant GV/2012/085. The authors acknowledge the collaboration of Sara Correa, Geles Viguer and Pepa Gabaldón from the Diabetes Reference Unit in the Clinic University Hospital of Valencia, and the selfless participation of all the patients involved in the experiments from which data were obtained.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Adaptive calibration algorithm for plasma glucose estimation in continuous glucose monitoring

  • Barceló-Rico, Fátima
  • Rossetti, Paolo
  • Vehi, Josep
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Minimally or noninvasive continuous glucose monitors estimate plasma glucose from compartments alternative to blood, and may revolutionize the management of diabetes. However, the accuracy of current devices is still poor and it may partly depend on low performance of the implemented calibration algorithm. Here, a new adaptive calibration algorithm based on a population local-model-based intercompartmental glucose dynamic model is proposed. The novelty consists in the adaptation of data normalization parameters in real time to estimate and compensate patient's sensitivity variations. Adaptation is performed to minimize mean absolute relative deviation at the calibration points with a time window forgetting strategy. Four calibrations are used: preprandial and 1.5 h postprandial at two different meals. Two databases are used for validation: 1) a 9-hCGMSGold (Medtronic, Northridge, USA) time series with paired reference glucose values from a clinical study in 17 subjects with type 1 diabetes; 2) data from 30 virtual patients (UVa simulator, Virginia, USA), where inter-and intrasubject variability of sensor's sensitivity were simulated. Results show how the adaptation of the normalization parameters improves the performance of the calibration algorithm since it counteracts sensor sensitivity variations. This improvement is more evident in one-week simulations., Manuscript received April 17, 2012; revised September 10, 2012 and January 21, 2013; accepted March 11, 2013. Date of publication March 19, 2013; date of current version May 1, 2013. This work was supported in part by the Spanish Ministry of Science and Innovation under Project DPI2010-20764-C02 and in part by the European Union under Grant FP7-PEOPLE-2009-IEF, Ref 252085. The work of F. Barcelo-Rico was supported by the Spanish Ministry of Education (FPU AP2008-02967).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Safety Auxiliary Feedback Element for the Artificial Pancreas in Type 1 Diabetes

  • Revert Tomás, Ana
  • Garelli, Fabricio
  • De Battista, Hernan
  • Rossetti, Paolo
  • Picó, Jesús|||0000-0003-4144-3521
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The artificial pancreas aims at the automatic deliv-ery of insulin for glycemic control in patients with type 1 diabetes, i.e., closed-loop glucose control. One of the challenges of the arti-ficial pancreas is to avoid controller overreaction leading to hypo-glycemia, especially in the late postprandial period. In this study, an original proposal based on sliding mode reference conditioning ideas is presented as a way to reduce hypoglycemia events induced by a closed-loop glucose controller. The method is inspired in the intuitive advantages of two-step constrained control algorithms. It acts on the glucose reference sent to the main controller shaping it so as to avoid violating given constraints on the insulin-on-board. Some distinctive features of the proposed strategy are that 1) it provides a safety layer which can be adjusted according to medical criteria; 2) it can be added to closed-loop controllers of any nature; 3) it is robust against sensor failures and overestimated prandial insulin doses; and 4) it can handle nonlinear models. The method is evaluated in silico with the ten adult patients available in the FDA-accepted UVA simulator., This work was supported in part by the FEDER-CICYT under Grant DPI2008-06880-C03-01, Grant DPI2011-28112-C04-01, and Grant DPI2010-20764-C02, in part by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant FP7-PEOPLE-2009-IEF Ref 252085, and in part by the Argentinian Government under Grant ANPCyT PICT-2011-0888, Grant CONICET PIP112-2011-00361, and Grant UNLP I164. The work of A. Revert was supported by the Spanish Ministry of Science and Innovation fellowship under Grant FPI BES-2009-020327.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Real-Time Continuous Glucose Monitoring in an Intensive Care Unit: Better Accuracy in Patients with Septic Shock

  • Lorencio, Carol
  • Leal, Yenny
  • Bonet Alonso, Alfonso
  • Palerm, César C.
  • Tache, Abdo
  • Sirvent, Josep Maria
  • Vehi, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: This study assessed the accuracy of real-time continuous glucose monitoring system (RTCGMS) devices in an intensive care unit (ICU) to determine whether the septic status of the patient has any in¿uence on the accuracy of the RTCGMS. Subjects and Methods: In total, 41 patients on insulin therapy were included. Patients were monitored for 72 h using RTCGMS. Arterial blood glucose (ABG) samples were obtained following the protocol established in the ICU. The results were evaluated using paired values (excluding those used for calibration) with the performance assessed using numerical accuracy. Nonparametric tests were used to determine statistically signi¿cant differences in accuracy. Results: In total, 956 ABG/RTCGMS pairs were analyzed. The overall median relative absolute difference (RAD) was 13.5%, and the International Organization for Standardization (ISO) criteria were 68.1%. The median RADs reported for patients with septic shock, with sepsis, and without sepsis were 11.2%, 14.3%, and 16.3%, respectively (P<0.05). Measurements meeting the ISO criteria were 74.5%, 65.6%, and 63.7% for patients with septic shock, with sepsis, and without sepsis, respectively (P<0.05). Conclusions: The results showed that the septic status of patients in¿uenced the accuracy of the RTCGMS in the ICU. Accuracy was signi¿cantly better in patients with septic shock in comparison with the other patient cohorts., This work was supported by the Spanish Ministry of Science and Innovation through grants DPI2007-66728-C02 and DPI-2010-20764-C02, the European Union through FEDER funds, and the Autonomous Government of Catalonia through 2009 SGR 523. Y.L. is grateful for the BR Grants of the University of Girona. The authors thank the Ph.D. candidate student Xavier Berjaga, who helped with the statistical analysis in this work. The authors thank the nursing staff of the ICU of Doctor Josep Trueta Hospital for their work; without them, this study could not have been conducted. Medtronic, Inc. provided some of the devices used in this study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Improving the computational effort of set-inversion-based prandial insulin delivery for its integration in insulin pumps

  • León-Vargas, Fabián
  • Calm, Remei
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for postprandial glucose control in type 1 diabetes mellitus (T1DM). It automatically coordinates the values of basal-bolus insulin to be infused during the postprandial period so as to achieve some predefined control objectives. However, the method requires an excessive computation time to compute the solution set of feasible insulin profiles, which impedes its integration into an insulin pump. In this work, a new algorithm is presented, which reduces computation time significantly and enables the integration of this new bolus advisor into current processing features of smart insulin pumps. Methods: A new strategy was implemented that focused on finding the combined basal-bolus solution of interest rather than an extensive search of the feasible set of solutions. Analysis of interval simulations, inclusion of physiological assumptions, and search domain contractions were used. Data from six real patients with T1DM were used to compare the performance between the optimized and the conventional computations. Results: In all cases, the optimized version yielded the basal-bolus combination recommended by the conventional method and in only 0.032% of the computation time. Simulations show that the mean number of iterations for the optimized computation requires approximately 3.59 s at 20 MHz processing power, in line with current features of smart pumps. Conclusions: A computationally efficient method for basal-bolus coordination in postprandial glucose control has been presented and tested. The results indicate that an embedded algorithm within smart insulin pumps is now feasible. Nonetheless, we acknowledge that a clinical trial will be needed in order to justify this claim., This work was partially supported by the Spanish Ministry of Science and Innovation through Grant DPI-2010-20764-C02 and by the Autonomous Government of Catalonia through Grant SGR 523. Fabian León-Vargas acknowledges the FI grants of Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

On the Computation of Output Bounds for Compartmental in-Series Models under Parametric Uncertainty

  • de Pereda Sebastián, Diego
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] In this work, the problem of obtaining tight output bounds for compartmental in-series models under parametric uncertainty is addressed. It is well-known that current methods used to compute a solution envelope may produce a significant overestimation. However, monotonicityanalysis enables us to estimate a tight solution envelope. Our main aim is to get an equivalent model to the initial one, which is usually non-monotone, by means of a suitable combination of equations. In this new model the system monotonicity with respect to the uncertain parameters depends on the elimination rate values of the original model. If the equivalent model is monotone, no overestimation occurs in the computation of the output bounds., This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion through Grant DPI-2010- 20764-C02, and by the Generalitat Valenciana through Grant GV/2012/085.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Prediction of postprandial blood glucose under uncertainty and intra-patient variability in type 1 diabetes: a comparative study of three interval models,

  • García Jaramillo, Maira Alejandra
  • Calm, R.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
The behavior of three insulin action and glucose kinetics models was assessed for an insulin therapy regime in the presence of patient variability. For this purpose, postprandial glucose in patients with type 1 diabetes was predicted by considering intra- and inter-patient variability using modal interval analysis. Equations to achieve optimal prediction are presented for models 1, 2 and 3, which are of increasing complexity. The model parameters were adjusted to reflect the “same” patient in the presence of variability. The glucose response envelope for model 1, the simplest insulin–glucose model assessed, included the responses of the other two models when a good fit of the model parameters was achieved. Thus, under variability, simple glucose–insulin models may be sufficient to describe patient dynamics in most situations., This work was partially supported by the Spanish Ministry of Science and Innovation through Grant DPI-2010-20764-C02, and by the Autonomous Government of Catalonia through Grant SGR 523.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Calculation of the Best Basal-Bolus Combination for Postprandial Glucose Control in Insulin Pump Therapy

  • Revert, Ana
  • Calm, Remei
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Intensive insulin therapy in type 1 diabetes is based on the well-established practice of adjusting basal and bolus insulin independently. Basal insulin delivery is designed to optimize glucose concentrations between meals and overnight, while bolus insulin delivery is designed to optimize postprandial glucose concentrations. However, this strategy shows some limitations in the postprandial glucose control, especially for meals with high carbohydrate content. Strategies based on coordinating basal and bolus insulin in the postprandial period help in overcoming these limitations. An algorithm, based on mathematically guaranteed techniques (interval analysis), is presented in this paper. It determines, given the current glycemic state of the patient and the meal to be ingested, a basal-bolus combination that will yield a tight postprandial glycemic control according to the International Diabetes Federation guidelines. For a given meal, the algorithm reveals which bolus administration mode will enable a good postprandial performance: standard, square-wave, dual-wave, or temporal basal decrement. The algorithm is validated through an in silico study using the 30 subjects in the educational version of the Food and Drug Administration accepted University of Virginia simulator., This work was supported by the Spanish Government under Grants DPI-2007-66728 and DPI-2010-20764-C02, by the FEDER funds from European Union, by the Generalitat de Catalunya under Grant SGR-00296, and by the PAID-05-08 program of the Universidad Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A multiple local models approach to accuracy improvement in continuous glucose monitoring

  • Barceló Rico, Fátima
  • Rossetti ., Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Diez, José-Luís|||0000-0002-5659-1212
[EN] Background: Continuous glucose monitoring (CGM) devices estimate plasma glucose (PG) from measurements in compartments alternative to blood. The accuracy of currently available CGM is yet unsatisfactory and may depend on the implemented calibration algorithms, which do not compensate adequately for the differences of glucose dynamics between the compartments. Here we propose and validate an innovative calibration algorithm for the improvement of CGM performance. Methods: CGM data from GlucoDay (R) (A. Menarini, Florence, Italy) and paired reference PG have been obtained from eight subjects without diabetes during eu-, hypo-, and hyperglycemic hyperinsulinemic clamps. A calibration algorithm based on a dynamic global model (GM) of the relationship between PG and CGM in the interstitial space has been obtained. The GM is composed by independent local models (LMs) weighted and added. LMs are defined by a combination of inputs from the CGM and by a validity function, so that each LM represents to a variable extent a different metabolic condition and/or sensor-subject interaction. The inputs best suited for glucose estimation were the sensor current I and glucose estimations (G) over cap, at different time instants [I-k, Ik-1, (G) over cap (k-1)] (IIG). In addition to IIG, other inputs have been used to obtain the GM, achieving different configurations of the calibration algorithm. Results: Even in its simplest configuration considering only IIG, the new calibration algorithm improved the accuracy of the estimations compared with the manufacturer's estimate: mean absolute relative difference (MARD) = 10.8 +/- 1.5% versus 14.7 +/- 5.4%, respectively (P = 0.012, by analysis of variance). When additional exogenous signals were considered, the MARD improved further (7.8 +/- 2.6%, P<0.05). Conclusions: The LM technique allows for the identification of intercompartmental glucose dynamics. Inclusion of these dynamics into the calibration algorithm improves the accuracy of PG estimations., The authors acknowledge the partial funding of this work by the Spanish Ministry of Science and Innovation projects DPI2007-66728-C02-01 and DPI2010-20764-C02-01 and by the European Union through FEDER funds and grant FP7-PEOPLE-2009-IEF, Reference 252085. F.B.R. is the recipient of a fellowship (FPU AP2008-02967) from the Spanish Ministry of Education.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements

  • de Pereda Sebastián, Diego
  • Rossetti, Paolo
  • Ampudia Blasco, Francisco Javier
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Bondía Company, Jorge|||0000-0001-7286-3719
Continuous glucose monitors can measure interstitial glucose concentration in real time for closed-loop glucose control systems, known as artificial pancreas. These control systems use an insulin feedback to maintain plasma glucose concentration within a narrow and safe range, and thus to avoid health complications. As it is not possible to measure plasma insulin concentration in real time, insulin models have been used in literature to estimate them. Nevertheless, the significant interand intra-patient variability of insulin absorption jeopardizes the accuracy of these estimations. In order to reduce these limitations, our objective is to perform a real-time estimation of plasma insulin concentration from continuous glucose monitoring (CGM). Hovorka s glucose insulin model has been incorporated in an extended Kalman filter in which different selected time-variant model parameters have been considered as extended states. The observability of the original Hovorka s model and of several extended models has been evaluated by their Lie derivatives. We have evaluated this methodology with an in-silico study with 100 patients with Type 1 diabetes during 25 h. Furthermore, it has been also validated using clinical data from 12 insulin pump patients with Type 1 diabetes who underwent four mixed meal studies. Real-time insulin estimations have been compared to plasma insulin measurements to assess performance showing the validity of the methodology here used in comparison with that formerly used for insulin models. Hence, real-time estimations for plasma insulin concentration based on subcutaneous glucose monitoring can be beneficial for increasing the efficiency of control algorithms for the artificial pancreas., This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion through Grant DPI-2010-20764-C02-01 and Grant DPI-2013-46982-C2-1-R, and the European Union through FEDER fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

On the computation of output bounds on parallel inputs pharmacokinetic models with parametric uncertainty

  • de Pereda Sebastián, Diego
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Bondía Company, Jorge|||0000-0001-7286-3719
Pharmacokinetic models are of utmost importance in drug and medical research. The class of parallel inputs models consists of two or more linear chains connected together in parallel. It has been used to represent pharmacokinetic processes in which the input shows effects on the output with different delays in time. Due to physiological variability, the exact values of the model parameters are uncertain, but they can be bounded by intervals. In this case, the computation of output bounds can be posed as the solution of an initial value problem (IVP) for ordinary differential equations (ODEs) with uncertain initial conditions. However, current methods may produce a significant overestimation. In this paper, a new method to minimise overestimation when using the parallel inputs model is proposed and applied to two cases: subcutaneous insulin absorption for artificial pancreas research, and the study of the double-peak phenomenon observed for certain drugs. Our proposal consists in performing a model reduction in conjunction with analytical solutions of the input chains and a monotonicity analysis of model states and parameters. This method allows obtaining tighter output bounds with low computational cost compared to the latest techniques., This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion through Grant DPI-2010-20764-C02, and by the Universitat Politecnica de Valencia through Grant PAID-05-09-4334.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A simple robust method for estimating the glucose rate of appearance from mixed meals

  • Herrero, P.
  • Palerm, C.C.
  • Vehí, J.
  • Georgiou, P.
  • Oliver, N.
  • Toumazou, C.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Estimating the rate of glucose appearance (Ra) after ingestion of a mixed meal may be highly valuable in diabetes management. The gold standard technique for estimating Ra is the use of a multitracer oral glucose protocol. However, this technique is complex and is usually not convenient for large studies. Alternatively, a simpler approach based on the glucose-insulin minimal model is available. The main drawback of this last approach is that it also requires a gastrointestinal model, something that may lead to identifiability problems. Methods: In this article, we present an alternative, easy-to-use method based on the glucose-insulin minimal model for estimation of Ra. This new technique avoids complex experimental protocols by only requiring data from a standard meal tolerance test. Unlike other model-based approaches, this new approach does not require a gastrointestinal model, which leads to a much simpler solution. Furthermore, this novel technique requires the identification of only one parameter of the minimal model because the rest of the model parameters are considered to have small variability. In order to account for such variability as well as to account for errors associated to measurements, interval analysis has been employed. Results: The current technique has been validated using data from a United States Food and Drug Administration-accepted type 1 diabetes simulator [root mean square error (RMSE) = 0.77] and successfully tested with two clinical data sets from the literature (RMSE = 0.69). Conclusions: The presented technique for the estimation of Ra showed excellent results when tested with simulated and actual clinical data. The simplicity of this new technique makes it suitable for large clinical research studies for the evaluation of the role of Ra in patients with impairments in glucose metabolism. In addition, this technique is being used to build a model library of mixed meals that could be incorporated into diabetic subject simulators in order to account for more realistic and varied meals., This work has been funded by the Wellcome Trust, the Spanish Ministry of Science and Innovation through grant DPI2010-20764-C02, the European Union through FEDER funds, and Generalitat de Catalunya under Grant 2009 SGR 523.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

On the prediction of glucose concentration under intra-patient variability in type 1 diabetes: A monotone systems approach

  • de Pereda Sebastián, Diego
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Bondía Company, Jorge|||0000-0001-7286-3719
Insulin therapy in type 1 diabetes aims to mimic the pattern of endogenous insulin secretion found in healthy subjects. Glucose-insulin models are widely used in the development of new predictive control strategies in order to maintain the plasma glucose concentration within a narrow range, avoiding the risks of high or low levels of glucose in the blood. However, due to the high variability of this biological process, the exact values of the model parameters are unknown, but they can be bounded by intervals. In this work, the computation of tight glucose concentration bounds under parametric uncertainty for the development of robust prediction tools is addressed. A monotonicity analysis of the model states and parameters is performed. An analysis of critical points, state transformations and application of differential inequalities are proposed to deal with non-monotone parameters. In contrast to current methods, the guaranteed simulations for the glucose-insulin model are carried out by considering uncertainty in all the parameters and initial conditions. Furthermore, no time-discretisation is required, which helps to reduce the computational time significantly. As a result, we are able to compute a tight glucose envelope that bounds all the possible patient's glycemic responses with low computational effort. (C) 2012 Elsevier Ireland Ltd. All rights reserved., This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion through Grant DPI-2010-20764-C02, by the Universitat Politecnica de Valencia through Grant PAID-05-09-4334, and by the Generalitat Valenciana through Grant GV/2012/085.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Laguna Sanz, Alejandro José
  • Revert Tomás, Ana
  • Vehí Casellas, Josep
  • Ascaso, Juan F.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: Prandial insulin dosing is an empirical practice associated frequently with poor reproducibility in postprandial glucose response. Based on continuous glucose monitoring (CGM), a method for prandial insulin administration (iBolus) is presented and evaluated for people with type 1 diabetes using CSII therapy. Subjects and Methods: An individual patient¿s model for a 5-h postprandial period was obtained from 6-day ambulatory CGM and used for iBolus calculation in 12 patients with type 1 diabetes. In a double-blind, crossover study each patient underwent four meal tests with 40 g or 100 g of carbohydrates (CHOs), both on two occasions. For each meal, the iBolus or the traditional bolus (tBolus) was given before mealtime (t 0) in a randomized order. We measured the postprandial glycemic response as the area under the curve of plasma glucose (AUC-PG0¿5h) and variability as the individual coef¿cient of variation (CV) of AUC-PG0¿5h. The contribution of the insulin-to-CHO ratio, CHO, plasma glucose at t 0 (PGt0), and insulin dose to AUC-PG0¿5h and its CV was also investigated. Results: AUC-PG0¿5h was similar with either bolus for 40-g (iBolus vs. tBolus, 585.5¿127.5 vs. 689.2¿180.7 mg/dL$h) or 100-g (752.1¿237.7 vs. 760.0¿263.2 mg/dL$h) CHO meals. A multiple regression analysis revealed a signi¿cant model only for the tBolus, with PGt0 being the best predictor of AUC-PG0¿5h explaining approximately 50% of the glycemic response. Observed variability was greater with the iBolus (CV, 16.7¿15.3% vs. 10.1¿12.5%) but independent of the factors studied. Conclusions: A CGM-based algorithm for calculation of prandial insulin is feasible, although it does not reduce unpredictability of individual glycemic responses. Causes of variability need to be identi¿ed and analyzed for further optimization of postprandial glycemic control., We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study. We also thanks Dr. Carmine Fanelli, University of Perugia, Dr. Howard Zisser, Sansum Diabetes Research Institute, and Prof. Alberto Ferrer, Universitat Politecnica de Valencia, for their suggestions on study design and data analysis. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007/2013) under grant agreement 252085 and from the Spanish Ministry of Science under grants DPI2010-20764-C02-01 and DPI2011-28112-C04-01.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Principal component analysis in combination with case-base reasoning for detecting therapeutically correct and incorrect measurements in continuous glucose monitoring

  • Leal, Yenny
  • Ruiz, Magda
  • Lorencio, Carol
  • Mujica, Luis
  • Vehi, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
This paper introduces a data-driven methodology for detecting therapeutically correct and incorrect measurements in continuous glucose monitoring systems (CGMSs) in an intensive care unit (ICU). The data collected from 22 patients in an ICU with insulin therapy were obtained following the protocol established in the ICU. Measurements were classified using principal component analysis (PCA) in combination with case-based reasoning (CBR), where a PCA model was built to extract features that were used as inputs of the CBR system. CBR was trained to recognize patterns and classify these data. Experimental results showed that this methodology is a potential tool to distinguish between therapeutically correct and incorrect measurements from a CGMS, using the information provided by the monitor itself, and incorporating variables about the patient’s clinical condition., This work was supported by the Spanish Ministry of Science and Innovation under Grant DPI-2010-20764-C02, and by the Autonomous Government of Catalonia under Grant 2009 SGR 523. Yenny Leal is grateful for the BR Grants of the University of Girona. The authors would like to thank PhD student Xavier Berjaga, who helped with support of this work. The authors would like to thank the nursing and medical staff of the ICU of Doctor Josep Trueta Hospital for their work. They are also thankful to Medtronic, Inc., for providing some of the devices used in this study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Detection of correct and incorrect measurements in real-time continuous glucose monitoring systems applying a postprocessing support vector machine

  • Leal, Yenny
  • GONZALEZ-ABRIL, LUIS
  • Lorencio, Carol
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Support vector machines (SVMs) are an attractive option for detecting correct and incorrect measurements in real-time continuous glucose monitoring systems (RTCGMSs), because their learning mechanism can introduce a postprocessing strategy for imbalanced datasets. The proposed SVM considers the geometric mean to obtain a more balanced performance between sensitivity and specificity. To test this approach, 23 critically ill patients receiving insulin therapy were monitored over 72 h using an RTCGMS, and a dataset of 537 samples, classified according to International Standards Organization (ISO) criteria (372 correct and 165 incorrect measurements), was obtained. The results obtained were promising for patients with septic shock or with sepsis, for which the proposed system can be considered as reliable. However, this approach cannot be considered suitable for patients without sepsis., This work was supported by the Spanish Ministry of Science and Innovation under Grant DPI-2010-20764-C02, and by the Autonomous Government of Catalonia under Grant 2009 SGR 523. In addition, this work was partially supported by the Spanish Ministry of Economy and Competitiveness through ARTEMISA (TIN2009-14378-C02-01), and by the Andalusia Regional Ministry of Economy, Innovation and Science through Simon (TIC-8052). Y. Leal was supported by BR Grants of the University of Girona.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Identification of intra-patient variability in the postprandial response of patients with type 1 diabetes

  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background Identification of individualized models for patients with type 1 diabetes is of vital importance for the development of a successful artificial pancreas and other model-based strategies of insulin treatment. However, the huge intra-patient glycemic variability frequently prevents the identification of reliable models, especially in the postprandial period. In this work, the identification of postprandial models characterizing intra-patient variability is addressed. Methods Regarding the postprandial response, uncertainties due to physiological variability, input errors in insulin infusion rate and in meal content estimation are characterized by means of interval models, which predict a glucose envelope containing all possible patient responses according to the model. Multi-objective optimization is performed over a cohort of virtual patients, minimizing both the fitting error and the output glucose envelope width. A Pareto Front is then built ranging from classic identification representing average behaviors to interval identification guaranteeing full enclosure of the measurements. A method for the selection of the best individual in the Pareto Front for identification from home monitoring data with a continuous glucose monitor is presented, reducing the overestimation of patient's variability due to monitor inaccuracies and noise. Results Identification using glucose reference data provide model bands that accurately fit all data points in the used virtual data set. Identification from continuous glucose monitor data, using two different width estimation procedures yield very similar prediction capabilities of around 60% of the data points predicted, and less than a 5% average error. Conclusions In this work, a new approach to evaluate intra-patient variability in the identification of postprandial models is presented. The proposed method is feasible and shows good prediction capabilities in a 5-h time horizon as compared to reference measurements., This work received funding from the Spanish Ministry of Science and Innovation under grant DPI2010-20764-C02, from the Generalitat Valenciana under project GV/2012/085, andfromthe European UnionSeventhFramework Programme (FP7/2007-2013) under grant agreement FP7-PEOPLE-2009-IEF, Ref 252085. The authors would like to acknowledge the collaboration of Sara Correa, Geles Viguer and Pepa Gabaldón of the Diabetes Reference Unit from the Clinic University Hospital of Valencia and, in particular, all the patients for participating in the study used in this work.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Postprandial performance of Dexcom® SEVEN® PLUS and Medtronic® Paradigm® Veo : Modeling and statistical analysis

  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background Minimizing excessive postprandial glucose excursion is still an unmet need in treating diabetes. This work addresses the analysis and modeling in the postprandial state of two commercial CGM devices. Methods Twelve patients with type 1 diabetes were studied in the postprandial state on four different occasions under controlled conditions. Each time, we performed simultaneous glucose monitoring using the Dexcom SEVEN® PLUS (47 datasets) and the Medtronic Paradigm® Veo™ (42 datasets). The following statistical properties of the error signal were analyzed and modeled sequentially for the two devices: the lag time, the error stationarity, the error probability distribution and the time correlation. Finally, models were built for sensor simulation in silico studies. Results Lag time followed an exponential probability distribution for both monitors (μsevenplus = 108, μveo = 1.69). Standard deviation and mean of the error signal, calculated as time-dependent signals across the population of sensors, were time-varying and correlated with the reference value and its rate of change, respectively. In both cases, a high variability of postprandial behaviors was observed. After non-stationarity compensation, a logistic distribution was obtained for the SEVEN® PLUS error (close to normal distribution). Regarding the Paradigm® Veo™, a multimodal distribution was obtained, which turned into normal after elimination of five “unstable” sensors. Finally, a first order autoregressive model fitted the SEVEN® PLUS error time-series while a third-order filter was necessary for the Paradigm® Veo™. Conclusions The Paradigm® Veo™ device exhibited greater delay variability with higher delay time and higher probability of abnormal sensor behaviors as compared to the SEVEN® PLUS device. In both cases, the observed variability may have important clinical implications in postprandial performance. Therefore, further improvements are needed in calibration algorithms to reduce this variability., The research leading to these results has received funding from the Spanish Ministry of Science and Innovation under grant DPI2010-20764-C02-01, the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement FP7-PEOPLE-2009-IEF, Ref 252085 and the Generalitat Valenciana through Grant GV/2012/085. The authors acknowledge the collaboration of Sara Correa, Geles Viguer and Pepa Gabaldón from the Diabetes Reference Unit in the Clinic University Hospital of Valencia, and the selfless participation of all the patients involved in the experiments from which data were obtained.